Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO-0

<p><b>Copyright information:</b></p><p>Taken from "Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO"</p><p>http://www.translational-medicine.com/content/5/1/53</p><p>Journal of Translational Medicine 2007;5():53-53.</p><p>Published online 30 Oct 2007</p><p>PMCID:PMC2174439.</p><p></p>ination of 100 ng/ml SCF and 10 ng/ml Flt3-L. (b) Responses of five different patients showing that in general 10 ng/ml Flt3-L gives a greater response than 100 ng/ml Flt3-L in combination with 100 ng/ml SCF. (c) Responses of a representative patient's CD34cells to 100 ng/ml SCF + 10 ng/ml Flt3-L added at day zero, alone or with 100 ng/ml G-CSF added at day zero or day 7. (d) Range of five patients' responses to 100 ng/ml SCF + 10 ng/ml Flt3-L + 100 ng/ml G-CSF (these are a different five patients from those shown in b)

Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO-4

<p><b>Copyright information:</b></p><p>Taken from "Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO"</p><p>http://www.translational-medicine.com/content/5/1/53</p><p>Journal of Translational Medicine 2007;5():53-53.</p><p>Published online 30 Oct 2007</p><p>PMCID:PMC2174439.</p><p></p> and without G-CSF and the effect of TPO on these combinations. The baseline (no PMA) is for the SCF/Flt3-L/G-CSF combination: the baselines for the other cytokine combinations overlaid this baseline and are not shown

Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources-0

<p><b>Copyright information:</b></p><p>Taken from "Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources"</p><p>http://www.translational-medicine.com/content/5/1/37</p><p>Journal of Translational Medicine 2007;5():37-37.</p><p>Published online 18 Jul 2007</p><p>PMCID:PMC1949398.</p><p></p>arrow (BM), umbilical cord blood (CB) and G-CSF-mobilised peripheral blood samples (mPBP) from patients for autologous grafts

Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources-3

<p><b>Copyright information:</b></p><p>Taken from "Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources"</p><p>http://www.translational-medicine.com/content/5/1/37</p><p>Journal of Translational Medicine 2007;5():37-37.</p><p>Published online 18 Jul 2007</p><p>PMCID:PMC1949398.</p><p></p>n = 7), cord blood (CB)(n = 11) and G-CSF-mobilised peripheral blood samples (mPBP, patient (n = 11); or mPBD, donor (n = 5)). (*** p < 0.001, Mann-Whitney test)

Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources-2

<p><b>Copyright information:</b></p><p>Taken from "Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources"</p><p>http://www.translational-medicine.com/content/5/1/37</p><p>Journal of Translational Medicine 2007;5():37-37.</p><p>Published online 18 Jul 2007</p><p>PMCID:PMC1949398.</p><p></p>sing VEGFR2 in the different sources tested and Number 3c) and percentage 3f) of CD34CD133cells co-expressing VEGFR2 in the different sources tested. Note different Y axis scales between figures

Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO-2

<p><b>Copyright information:</b></p><p>Taken from "Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO"</p><p>http://www.translational-medicine.com/content/5/1/53</p><p>Journal of Translational Medicine 2007;5():53-53.</p><p>Published online 30 Oct 2007</p><p>PMCID:PMC2174439.</p><p></p>ent's responses in SCF + Flt3-L + G-CSF with or without TPO. These are different patients from those shown in figure 1

Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO-3

<p><b>Copyright information:</b></p><p>Taken from "Optimal expansion of neutrophils from PBSC CD34cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO"</p><p>http://www.translational-medicine.com/content/5/1/53</p><p>Journal of Translational Medicine 2007;5():53-53.</p><p>Published online 30 Oct 2007</p><p>PMCID:PMC2174439.</p><p></p>orphology. Any cells with non-neutrophil morphological changes were classed as others. Bars represent mean and standard error; lines connect the scores for each cytokine cocktail so that curve shifts can be seen